Compare GeneDx Holdings Corp (WGS) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GeneDx Holdings Corp vs Zimmer Biomet Holdings Inc — how do they compare? GeneDx Holdings Corp trades at $61.92 (market cap $1.80B), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 9.6× GeneDx Holdings Corp's market cap, and Zimmer Biomet Holdings Inc pays a 1.07% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| WGS | ZBH | |
|---|---|---|
Market Cap | $1.80B | $17.36B |
Sector | Technology | Health |
52-Week High | $167.51 | $107.71 |
52-Week Low | $34.51 | $79.58 |
Enterprise Value | $1.80B | $24.40B |
Dividend Yield | — | 1.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
